المؤلفون: Villacampa, G, Tung, N M, Pernas, S, Paré, L, Bueno-Muiño, C, Echavarría, I, López-Tarruella, S, Roche-Molina, M, Del Monte-Millán, M, Marín-Aguilera, M, Brasó-Maristany, F, Waks, A G, Pascual, T, Martínez-Sáez, O, Vivancos, A, Conte, P F, Guarneri, V, Vittoria Dieci, M, Griguolo, G, Cortés, J, Llombart-Cussac, A, Muñoz, M, Vidal, M, Adamo, B, Wolff, A C, DeMichele, A, Villagrasa, P, Parker, J S, Perou, C M, Fernandez-Martinez, A, Carey, L A, Mittendorf, E A, Martín, M, Prat, A, Tolaney, S M

المساهمون: Villacampa, G, Tung, N M, Pernas, S, Paré, L, Bueno-Muiño, C, Echavarría, I, López-Tarruella, S, Roche-Molina, M, Del Monte-Millán, M, Marín-Aguilera, M, Brasó-Maristany, F, Waks, A G, Pascual, T, Martínez-Sáez, O, Vivancos, A, Conte, P F, Guarneri, V, Vittoria Dieci, M, Griguolo, G, Cortés, J, Llombart-Cussac, A, Muñoz, M, Vidal, M, Adamo, B, Wolff, A C, Demichele, A, Villagrasa, P, Parker, J S, Perou, C M, Fernandez-Martinez, A, Carey, L A, Mittendorf, E A, Martín, M, Prat, A, Tolaney, S M

مصطلحات موضوعية: HER2, HER2DX, breast cancer, neoadjuvant, pathological complete response, pertuzumab

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37302750; info:eu-repo/semantics/altIdentifier/wos/WOS:001065301400001; numberofpages:13; journal:ANNALS OF ONCOLOGY; https://hdl.handle.net/11577/3491164Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85165687043; https://www.sciencedirect.com/science/article/pii/S0923753423007214?via=ihubTest

الإتاحة: https://doi.org/10.1016/j.annonc.2023.05.012Test
https://hdl.handle.net/11577/3491164Test
https://www.sciencedirect.com/science/article/pii/S0923753423007214?via=ihubTest

المؤلفون: Villacampa, G, Tung, N.M, Pernas, S, Paré, L, Bueno-Muiño, C, Echavarría, I, López-Tarruella, S, Roche-Molina, M, del Monte-Millán, M, Marín-Aguilera, M, Brasó-Maristany, F, Waks, A.G, Pascual, T, Martínez-Sáez, O, Vivancos, A, Conte, P.F, Guarneri, V, Dieci, M.V., Griguolo, G, Cortés, J, Llombart-Cussac, A, Muñoz, M, Vidal, M, Adamo, B, Wolff, A.C, DeMichele, A, Villagrasa, P, Parker, J.S, Perou, C.M, Fernandez-Martinez, A, Carey, L.A, Mittendorf, E.A, Martín, M, Prat, A., Tolaney, S.M.

المصدر: Annals of Oncology, 34(9)

مصطلحات موضوعية: HER2DX, HER2, breast cancer, neoadjuvant, pathological complete response, pertuzumab

العلاقة: https://doi.org/10.17615/dk2r-gd08Test; https://cdr.lib.unc.edu/downloads/k3569g05z?file=thumbnailTest; https://cdr.lib.unc.edu/downloads/k3569g05zTest

الإتاحة: https://doi.org/10.17615/dk2r-gd08Test
https://cdr.lib.unc.edu/downloads/k3569g05z?file=thumbnailTest
https://cdr.lib.unc.edu/downloads/k3569g05zTest

المؤلفون: Gelmon K. A., Fasching P. A., Couch F. J., Balmana J., Delaloge S., Labidi-Galy I., Bennett J., McCutcheon S., Walker G., O'Shaughnessy J., Timcheva C., Tomova A., Eisen A., Lemieux J., Bazan F., Bourgeois H., Chakiba C., Chehimi M., Dalenc F., De La Motte Rouge T., Frenel J. -S., Goncalves A., Hardy-Bessard A. C., Lamy R., Levy C., Lortholary A., Mailliez A., Medioni J., Patsouris A., Spaeth D., Teixeira L., Tennevet I., Villanueva C., You B., Ettl J., Gerber B., Hoffmann O., Park-Simon T. -W., Reinisch M., Tio J., Wimberger P., Boer K., Ballestrero A., Bianchini G., Biganzoli L., Bordonaro R., Cognetti F., De Laurentiis M., De Placido S., Guarneri V., Montemurro F., Naso G., Santoro A., Zamagni C., Kim S. -J., Nakamura S., Chae Y. S., Cho E. K., Hyun K. J., Im S. -A., Lee K. S., Park Y. H., Sohn J. H., Byrski T., Huzarski T., Kukielka-Budny B., Nowecki Z., Szoszkiewicz R., Tarnawski R., Dvornichenko V., Moiseenko F., Mukhametshina G., Poddubskaya E., Popova E., Tarasova A., Vats A., Adamo B., Conejero R. A., Torres A. A., Gelpi J. B., Fernandez N. D., Gonzalez A. F., Garcia J., Lorenzo-Lorenzo I., Anton F. M., Santisteban M., Stradella A., Huang C. -S., Aksoy S., Arslan C., Artac M., Aydiner A., Ozyilkan O., Sezer E., Armstrong A., Barrett S., Borley A., Kemp Z., Michie C., Mukesh M., Perren T., Swampillai A., Young T.

المساهمون: Gelmon, K. A., Fasching, P. A., Couch, F. J., Balmana, J., Delaloge, S., Labidi-Galy, I., Bennett, J., Mccutcheon, S., Walker, G., O'Shaughnessy, J., Timcheva, C., Tomova, A., Eisen, A., Lemieux, J., Bazan, F., Bourgeois, H., Chakiba, C., Chehimi, M., Dalenc, F., De La Motte Rouge, T., Frenel, J. -S., Goncalves, A., Hardy-Bessard, A. C., Lamy, R., Levy, C., Lortholary, A., Mailliez, A., Medioni, J., Patsouris, A., Spaeth, D., Teixeira, L., Tennevet, I., Villanueva, C., You, B., Ettl, J., Gerber, B., Hoffmann, O., Park-Simon, T. -W., Reinisch, M., Tio, J., Wimberger, P., Boer, K., Ballestrero, A., Bianchini, G., Biganzoli, L., Bordonaro, R., Cognetti, F., De Laurentiis, M., De Placido, S., Guarneri, V., Montemurro, F., Naso, G., Santoro, A., Zamagni, C., Kim, S. -J., Nakamura, S., Chae, Y. S., Cho, E. K., Hyun, K. J., Im, S. -A., Lee, K. S., Park, Y. H., Sohn, J. H., Byrski, T., Huzarski, T., Kukielka-Budny, B., Nowecki, Z., Szoszkiewicz, R., Tarnawski, R., Dvornichenko, V., Moiseenko, F., Mukhametshina, G., Poddubskaya, E., Popova, E., Tarasova, A., Vats, A., Adamo, B., Conejero, R. A., Torres, A. A., Gelpi, J. B., Fernandez, N. D., Gonzalez, A. F., Garcia, J., Lorenzo-Lorenzo, I., Anton, F. M., Santisteban, M., Stradella, A., Huang, C. -S., Aksoy, S., Arslan, C., Artac, M., Aydiner, A., Ozyilkan, O., Sezer, E., Armstrong, A., Barrett, S., Borley, A., Kemp, Z., Michie, C., Mukesh, M.

مصطلحات موضوعية: BRCA1 gene, BRCA2 gene, Breast cancer, Effectiveness, Germline mutation, Metastatic, Olaparib, Progression-free survival, Treatment outcome

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000678059500008; volume:152; firstpage:68; lastpage:77; numberofpages:10; journal:EUROPEAN JOURNAL OF CANCER; https://hdl.handle.net/20.500.11768/161557Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85107637276

الإتاحة: https://doi.org/20.500.11768/16155710.1016/j.ejca.2021.03.029Test
https://hdl.handle.net/20.500.11768/161557Test